Brienza Nicola, Giglio Maria Teresa, Marucci Massimo, Fiore Tommaso
Department of Emergency and Organ Transplantation, Anesthesia and Intensive Care Unit, University of Bari, Italy.
Crit Care Med. 2009 Jun;37(6):2079-90. doi: 10.1097/CCM.0b013e3181a00a43.
Postoperative acute deterioration in renal function, producing oliguria and/or increase in serum creatinine, is one of the most serious complication in surgical patients. Most cases are due to renal hypoperfusion as a consequence of systemic hypotension, hypovolemia, and cardiac dysfunction. Although some evidence suggests that perioperative monitoring and manipulation of oxygen delivery by volume expansion and inotropic drugs may decrease mortality in surgical patients, no study analyzed this approach on postoperative renal dysfunction. The objective of this investigation is to perform a meta-analysis on the effects of perioperative hemodynamic optimization on postoperative renal dysfunction. DATA SOURCES, STUDY SELECTION, DATA EXTRACTION: A systematic literature review, using MEDLINE, EMBASE, and The Cochrane Library databases through January 2008 was conducted and 20 studies met the inclusion criteria (4220 participants). Data synthesis was obtained by using odds ratio (OR) with 95% confidence interval (CI) by random-effects model.
Postoperative acute renal injury was significantly reduced by perioperative hemodynamic optimization when compared with control group (OR 0.64; CI 0.50-0.83; p = 0.0007). Perioperative optimization was effective in reducing renal injury defined consistently with risk, injury, failure, and loss and end-stage kidney disease and Acute Kidney Injury Network classifications, and in studies defining renal dysfunction by serum creatinine and/or need of renal replacement therapy only (OR 0.66; CI 0.50-0.88; p = 0.004). The occurrence of renal dysfunction was reduced when treatment started both preoperatively and intraoperatively or postoperatively, was performed in high-risk patients, and was obtained by fluids and inotropes. Mortality was significantly reduced in treatment group (OR 0.50; CI 0.31-0.80; p = 0.004), but statistical heterogeneity was observed.
Surgical patients receiving perioperative hemodynamic optimization are at decreased risk of renal impairment. Because of the impact of postoperative renal complications on adverse outcome, efforts should be aimed to identify patients and surgery that would most benefit from perioperative optimization.
术后肾功能急性恶化,表现为少尿和/或血清肌酐升高,是外科患者最严重的并发症之一。大多数病例是由于系统性低血压、血容量不足和心功能不全导致的肾灌注不足。虽然有证据表明围手术期通过扩容和使用正性肌力药物监测和调控氧输送可能降低外科患者的死亡率,但尚无研究分析这种方法对术后肾功能障碍的影响。本研究的目的是对围手术期血流动力学优化对术后肾功能障碍的影响进行荟萃分析。
数据来源、研究选择、数据提取:通过检索MEDLINE、EMBASE和考克兰图书馆数据库,进行了一项系统的文献综述,截止至2008年1月,有20项研究符合纳入标准(4220名参与者)。采用随机效应模型,通过比值比(OR)及95%置信区间(CI)进行数据合成。
与对照组相比,围手术期血流动力学优化显著降低了术后急性肾损伤的发生率(OR 0.64;CI 0.50 - 0.83;p = 0.0007)。围手术期优化对于降低符合风险、损伤、衰竭、丧失和终末期肾病及急性肾损伤网络分类标准定义的肾损伤有效,并且在仅通过血清肌酐和/或肾脏替代治疗需求定义肾功能障碍的研究中也有效(OR 0.66;CI 0.50 - 0.88;p = 0.004)。当在术前、术中或术后开始治疗,对高危患者进行治疗,并通过补液和使用正性肌力药物进行治疗时,肾功能障碍的发生率降低。治疗组的死亡率显著降低(OR 0.50;CI 0.31 - 0.80;p = 0.004),但观察到统计学异质性。
接受围手术期血流动力学优化的外科患者发生肾功能损害的风险降低。由于术后肾脏并发症对不良结局有影响,应努力识别最能从围手术期优化中获益的患者和手术方式。